News
Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...
GLP-1s - which mimic the effects of the hormone that stimulates insulin release, suppressing glucagon, and slowing gastric emptying - also have a range of other benefits.
The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?
First, a drug like Ozempic mimics the natural GLP-1 hormone in your gut, which slows down digestion in the stomach and ...
The hormonal changes of menopause can make the weight gain more resistant to traditional diet and lifestyle changes. But ...
Metformin is a safe, effective and cheap, and is showing it has promise for longevity, long Covid, weight control and other ...
Obesity is not a personal moral failing. It is a complex, multi-factorial condition driven by genetics, environment, and a ...
6d
News-Medical.Net on MSNCan one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonistsLandmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...
3d
Best Life on MSNDoctors Sound Alarm on Weight-Loss Drugs and Death RiskRELATED: Doctors Warn That Drugs Like Ozempic Are Making You “Skinny Fat.” Any time a person suddenly loses weight, they are ...
People are injecting peptides to build muscle, trim fat, and reduce inflammation. Does it work?
There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...
Researchers have revealed liver cancer cases are set to soar by 2050, with a problem on the rise in the UK driving the surge.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results